1Lai GM,Chen YN,Mickley LA,et al.P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.Int J Cancer,1991,49:696-703.
2Gutierrez M,Chabner BA,Pearson D,et al.Role of a doxorubicin-containing regimen in relapsea and resistant lymphomas:an 8-year follow-up study of EPOCH.J Clin Oncol,2000,21:3633-3642.
3Hara T,Tsurumi H,Kasahara S,et aLLow-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness[J].Int J Hematol,2005,82(5):430-436.
4Takamatsu Y, Suzumiya J,Utsunomiya A,et al.THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemial lymphoma: a multieenter phase II study [J].Eur J Haematol,2010,84(5): 391-397.
5Takamatsu Y,Suzumiya J,Utsunomiya A. THP -COP regimen for the treatment of peripheral T -cell lymphoma and adult T -cell leukemia/lymphoma:a multicenter phase II study[J].European Journal of Haematology,2010,(05):391-397.
6Bruce D;Cheson;Beate Pfistner.查看详情[J],Journal of Clinical Oncology200717-22.
